I am interested in cancer and how it interacts with our immune system. It is my belief that to push oncology forward we must adopt new strategies. Instead of relying solely on surgery, radiation or chemotherapy, cellular therapies – where we utilize the immune system – are poised to transform the way we treat and manage cancer.
Currently I am interested in three aspects of tumor-immunology: a) development of chimeric antigen receptor T-cells, b) exploration of genes that increase cytotoxicity of T-cells and c) defining surface markers on cancer cells suitable as targets.
2014: Olsen LR*, Campos B*, Barnkob MS*, Winther O, Brusic V, Andersen MH. Bioinformatics for cancer immunotherapy target discovery. Cancer Immunology, Immunotherapy, October 2014. Review. [Link].
2013: Bak SP*, Barnkob MS*, Wittrup KD, Chen J. Immunoediting of Antigen Expressing Cells after Treatment with Prostate Tumor Specific T Cells. Cancer Immunology Research, September 2013. [Link]
2012: Bak SP, Barnkob MS, Bai A, Higham EM, Wittrup KD, Chen J. Differential Requirement for CD70 and CD80/CD86 in Dendritic Cell-Mediated Activation of Tumor-Tolerized CD8 T Cells. Journal of Immunology, August 2012. [Link]
*Shared first authorship.